Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...
GlobalData on MSN5d
Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5mDaiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m Daiichi Sankyo has finalised the acquisition of intellectual ...
Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Brookstone Capital Management lifted its holdings in KeyCorp (NYSE:KEY – Free Report) by 6.3% in the fourth quarter, ...
Hosted on MSN6d
Dai-ichi Life financial leverage to remain below 23%The planned bonds are expected to have a call option after 10 years. Fitch Ratings anticipates Dai-ichi Life's financial ...
The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.
Insurance firm Dai-ichi Life Insurance and telecommunications company NTT East have decided to suspend ads on the major ...
Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth plans
As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new ...
Most Asian stocks rose on Monday after major U.S. stock indexes rallied to close out their best week in two months Friday on ...
Daiichi will release e Senran Kagura as a new Pachinko game based on Marvelous' franchise in early February 2025 in Japan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback